BGMD OTC
BG Medicine, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2M
-43.8% ▼
5Y CAGR: +13.8%
Gross Profit
$1M
-42.1% ▼
5Y CAGR: +100.2%
Operating Income
-$5M
+37.1% ▲
Net Income
-$5M
+34.2% ▲
EPS (Diluted)
$-0.55
+44.4% ▲
EBITDA
-$5M
+29.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| Revenue | $2M | $3M | $4M | $3M | $2M |
| YoY Growth | +99.5% | +72.3% | +44.7% | -31.6% | -43.8% |
| Cost of Revenue | $619K | $957K | $1M | $956K | $505K |
| Gross Profit | $1M | $2M | $3M | $2M | $1M |
| Gross Margin | 62.1% | 66.0% | 65.9% | 65.7% | 67.8% |
| R&D Expenses | $8M | $8M | $4M | $2M | $2M |
| SG&A Expenses | $11M | $17M | $13M | $7M | $4M |
| Operating Expenses | $18M | $17M | $17M | $9M | $6M |
| Operating Income | -$17M | -$23M | -$14M | -$7M | -$5M |
| Operating Margin | -1070.1% | -807.4% | -352.9% | -264.2% | -295.7% |
| Interest Expense | $89K | $1M | $1M | $728K | $159K |
| Income Before Tax | -$18M | -$24M | -$16M | -$8M | -$5M |
| Tax Expense | -$323K | $0 | $0 | $0 | $0 |
| Net Income | -$18M | -$24M | -$16M | -$8M | -$5M |
| Net Margin | -1076.0% | -844.4% | -389.1% | -289.3% | -338.6% |
| EPS (Diluted) | $-3.99 | $-4.70 | $-2.33 | $-0.99 | $-0.55 |
| EBITDA | -$17M | -$22M | -$15M | -$7M | -$5M |
| Shares Outstanding | 4M | 5M | 7M | 8M | 10M |